SEC Form 4 · accession 0001192482-19-000073
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Ciaffoni
Officer — President and CEO · Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 11, 2019 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | F | 2,052 | $14.39 | D | 196,606 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.